These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 10553159

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study.
    Bernard M, Cartron G, Rachieru P, LeMevel A, Branger B, Le Maignan C, Berthou C, Ghandour C, Delwail V, Milpied N, Cassasus P, Celigny PS, Guyotat D, Lamy T, Desablens B, French GOELAMS Group.
    Haematologica; 2005 Jun; 90(6):802-9. PubMed ID: 15951293
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients.
    Zinzani PL, Bendandi M, Martelli M, Falini B, Sabattini E, Amadori S, Gherlinzoni F, Martelli MF, Mandelli F, Tura S, Pileri SA.
    J Clin Oncol; 1996 Mar; 14(3):955-62. PubMed ID: 8622045
    [Abstract] [Full Text] [Related]

  • 25. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B, Li YX, Fang H, Jin J, Liu XF, Yu ZH.
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [Abstract] [Full Text] [Related]

  • 26. [Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy].
    Hattori M, Motomura S, Tomita N, Taguchi J, Tanabe J, Sakai R, Fujisawa S, Fukawa H, Kanamori H, Mouri H, Maruta A, Kodama F, Okubo T.
    Rinsho Ketsueki; 1996 Feb; 37(2):101-8. PubMed ID: 8852026
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Intensive treatment of stage III-IV aggressive malignant lymphomas (protocol TPL-84).
    Colombat P, Guilhot F, Bordesoule D, Renou P, Benz-Lemoine E, Fouillard L, Drouet M, Tanzer J, Lamagnere JP.
    Haematologica; 1991 Feb; 76(6):479-84. PubMed ID: 1726492
    [Abstract] [Full Text] [Related]

  • 29. [Comparison of chemotherapy CHOP vs. CHOP/VIA in the treatment of aggressive non-Hodgkin's lymphoma: a randomized multicenter study of 132 patients. The PETHEMA group. Program for Study and Therapeutics of malignant hemopathies. Spanish Association of Hematology and Hemotherapy].
    López-Guillermo A, García-Conde J, Alvarez-Carmona AM, León P, Maldonado J, Alcalá A, Zubizarreta A, Sancho-Tello R, Carbonell F, Contreras E, Besses C, Hernando A, Fontanillas M, Montserrat E.
    Med Clin (Barc); 1998 May 09; 110(16):601-4. PubMed ID: 9656196
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Treatment of high risk non-Hodgkin's lymphoma].
    Sawada U.
    Rinsho Ketsueki; 1993 Apr 09; 34(4):403-10. PubMed ID: 7685431
    [Abstract] [Full Text] [Related]

  • 34. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF, Su YS, Liu DG, Jiang WQ, He YJ, Lin TY, Huang HQ, Zhang L, Xia ZJ, Li YH, Zhou ZM, Chen XQ, Xia Y, Zhen ZJ, Guan ZZ.
    Ai Zheng; 2004 Aug 09; 23(8):933-8. PubMed ID: 15301718
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma.
    Vranovsky A, Ladicka M, Lakota J.
    Neoplasma; 2008 Aug 09; 55(2):107-12. PubMed ID: 18652043
    [Abstract] [Full Text] [Related]

  • 37. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
    He YF, Zhang YJ, Li YH, Lin TY, Xia YF, Lu TX, Huang HQ, Jiang WQ, Xian CG, He YJ, Guan ZZ.
    Ai Zheng; 2006 Dec 09; 25(12):1538-42. PubMed ID: 17166382
    [Abstract] [Full Text] [Related]

  • 38. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
    Zhou SY, Shi YK, He XH, Zhang P, Dong M, Huang DZ, Yang JL, Zhang CG, Liu P, Yang S, Feng FY.
    Ai Zheng; 2005 Apr 09; 24(4):465-9. PubMed ID: 15820071
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
    Chen CI, Roitman D, Tsang R, Stewart AK, Keating A, Crump M.
    Bone Marrow Transplant; 2002 Dec 09; 30(12):885-91. PubMed ID: 12476281
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.